Skip to main content
Unchecking box will stop auto data updates
CSE Real-Time Last Sale CAD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 3.580
Day High 3.990
Open:3.850
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Description
Valens Groworks Corp is a Vancouver-based biotechnology company. It is primarily focused on medical strain genetics, organic cultivation and multiple product-development. The company operates in two related health Canada-licensed business segments involved in the scientific research of phytopharmaceutical material, specifically producing cannabis and cannabis-related products. Company operates in one business segment being the scientific research of phytopharmaceutical material, specifically producing cannabis and cannabis related products.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Latest Press Releases

Retailers Take Note U.S . Consumers Opinion of CBD Infused Products is Increasingly Positive
PR Newswire - Tue Apr 16, 7:45AM CDT
PR Newswire - CMTX
Tue Apr 16, 7:45AM CDT
A well-respected purveyor of cannabis industry reports, the Brightfield Group, is not shy about making projections. Not only do they comment on projected revenues, they also look at where the industry is going and how it will get there. They have recently pointed to a previously closed vertical. They said: "that retailers big box retailers, are "Going after CBD" Hard! If you read their report its easy to see why a recent report said: "New Report Predicts CBD Market Will Hit $22 Billion by 2022. A new analysis estimates that the CBD market could explode -- and outpace marijuana." The company also said on its website that: "CBD is growing faster than cannabis in the U.S. and will soon be a $22 billion industry. Its been flying under the radar but is set to explode having profound impacts on CPG and Pharma. We detail the category growth rates, leading brands, product innovation by segment. Big Box is ready confirms another source: "since CBD for medical use is legal in 46 states and CBD derived from hemp rather than marijuana (it, CBD) is legal in all states. Recently, this past month of March, CVS announced that it will: "begin selling hemp-derived CBD products in eight states. The national drug store chain will be marketing the topical cannabidiol products, such as creams, sprays and roll-ons, as "an alternative source of relief," CVS said in a statement to NBC News. CVS will also be partnering with a company to test and verify the quality of the CBD topicals sold in its drug stores." NBC News reported that: "CVS to sell CBD products in 800 stores in 8 states. We are carrying hemp-derived CBD products in select states to help meet consumer demand for alternative care options," said CVS Health Spokesperson, Mike DeAngelis. The items will be sold in Alabama, California, Colorado, Illinois, Indiana, Kentucky, Maryland and Tennessee." "It's a way to reduce the stigma for a product that really doesn't deserve to be stigmatized," said a nutritionist and cannabis practitioner. Active Companies from around the market with current developments this week include: The Greater Cannabis Company (OTC: GCAN), CBD Unlimited, Inc. (OTC: EDXC), Aphria Inc. (NYSE: APHA) (TSX: APHA), Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB), Valens GroWorks Corp. (CSE: VGW) (OTC: VGWCF).
Retailers Take Note U.S . Consumers Opinion of CBD Infused Products Is Increasingly Positive
Financial News Media - Tue Apr 16, 7:16AM CDT
Financial News Media - CMTX
Tue Apr 16, 7:16AM CDT
Palm Beach, FL - April 16, 2019 – A well-respected purveyor of cannabis industry reports, the , is not shy about making projections. Not only do they comment on projected revenues, they also look at the industry is going and it will get there. They have recently pointed to a previously closed vertical... They said: "... that retailers... big box retailers, are "Going after CBD." Hard! If you read their report its easy to see why... A recent report said: " New Report Predicts CBD Market Will Hit $22 Billion by 2022 ... A new analysis estimates that the CBD market could explode -- and outpace marijuana." The company also said on its website that: "CBD is growing faster than cannabis in the U.S. and will soon be a $22 billion industry. It's been flying under the radar but is set to explode having profound impacts on CPG and Pharma. We detail the category growth rates, leading brands, product innovation by segment... Big Box is ready confirms another source: "... since CBD for medical use is legal in 46 states and CBD derived from hemp rather than marijuana (it, CBD) is legal in all states. Recently, this past month of March, CVS announced that it will: "... begin selling hemp-derived CBD products in eight states. The national drug store chain will be marketing the topical cannabidiol products, such as creams, sprays and roll-ons, as "an alternative source of relief," CVS said in a to NBC News. CVS will also be partnering with a company to test and verify the quality of the CBD topicals sold in its drug stores." NBC News reported that: " CVS to sell CBD products in 800 stores in 8 states. We are carrying hemp-derived CBD products in select states to help meet consumer demand for alternative care options," said CVS Health Spokesperson, Mike DeAngelis. The items will be sold in Alabama, California, Colorado, Illinois, Indiana, Kentucky, Maryland and Tennessee." "It's a way to reduce the stigma for a product that really doesn't deserve to be stigmatized," said a nutritionist and cannabis practitioner. Active Companies from around the market with current developments this week include: (OTC: GCAN), (OTC: EDXC), (NYSE: APHA) (TSX: APHA), (NYSE: ACB) (TSX: ACB), (CSE: VGW) (OTC: VGWCF).
5 of the Largest Cannabis Extraction Companies
GlobeNewswire - Wed Mar 27, 7:29AM CDT
GlobeNewswire - CMTX
Wed Mar 27, 7:29AM CDT
Although often overshadowed by the importance of marijuana retail and branding, cannabis extraction is a vital component of any vertically integrated cannabis company. Not only do in-house extraction operations allow cannabis companies to avoid outsourcing costs, but it also enables the potential for additional revenue streams and more rapid product ideation.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 2.830 +35.34% increase
on 04/02/19
Period Open:3.200
Price movement based on the high, low and last over the given period.
4.050 -5.43% decrease
on 04/16/19
+0.630 (+19.69%) increase
since 03/18/19
3-Month 2.070 +85.02% increase
on 01/21/19
Period Open:2.100
Price movement based on the high, low and last over the given period.
4.050 -5.43% decrease
on 04/16/19
+1.730 (+82.38%) increase
since 01/18/19
52-Week 0.980 +290.82% increase
on 07/26/18
Period Open:1.790
Price movement based on the high, low and last over the given period.
4.050 -5.43% decrease
on 04/16/19
+2.040 (+113.97%) increase
since 04/18/18

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2019.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).